Condition
Epilepsia Partialis Continua
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
100.0%
3 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Terminated3
Clinical Trials (3)
Showing 3 of 3 trials
NCT03154307Not ApplicableTerminated
Repeated TMS at Low Frequencies to Reduce Seizure Occurrence
NCT02560597Not ApplicableTerminatedPrimary
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy
NCT02134366Phase 3TerminatedPrimary
Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Showing all 3 trials